[go: up one dir, main page]

AU2001261728A1 - Use of small molecule radioligands for diagnostic imaging - Google Patents

Use of small molecule radioligands for diagnostic imaging

Info

Publication number
AU2001261728A1
AU2001261728A1 AU2001261728A AU6172801A AU2001261728A1 AU 2001261728 A1 AU2001261728 A1 AU 2001261728A1 AU 2001261728 A AU2001261728 A AU 2001261728A AU 6172801 A AU6172801 A AU 6172801A AU 2001261728 A1 AU2001261728 A1 AU 2001261728A1
Authority
AU
Australia
Prior art keywords
radioligands
small molecule
diagnostic imaging
diagnostic
imaging
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2001261728A
Inventor
Richard E. Olson
Dietmar A. Seiffert
Lorin A. Thompson
Robert Zaczek
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bristol Myers Squibb Pharma Co
Original Assignee
DuPont Merck Pharmaceutical Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by DuPont Merck Pharmaceutical Co filed Critical DuPont Merck Pharmaceutical Co
Publication of AU2001261728A1 publication Critical patent/AU2001261728A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04—Organic compounds
    • A61K51/041—Heterocyclic compounds
    • A61K51/044—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins
    • A61K51/0468—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Optics & Photonics (AREA)
  • Physics & Mathematics (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
AU2001261728A 2000-05-17 2001-05-17 Use of small molecule radioligands for diagnostic imaging Abandoned AU2001261728A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US20468500P 2000-05-17 2000-05-17
US60/204,685 2000-05-17
PCT/US2001/016009 WO2001087354A2 (en) 2000-05-17 2001-05-17 Use of small molecule radioligands for diagnostic imaging

Publications (1)

Publication Number Publication Date
AU2001261728A1 true AU2001261728A1 (en) 2001-11-26

Family

ID=22758997

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2001261728A Abandoned AU2001261728A1 (en) 2000-05-17 2001-05-17 Use of small molecule radioligands for diagnostic imaging

Country Status (3)

Country Link
US (2) US6878363B2 (en)
AU (1) AU2001261728A1 (en)
WO (1) WO2001087354A2 (en)

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6737038B1 (en) * 1998-11-12 2004-05-18 Bristol-Myers Squibb Company Use of small molecule radioligands to discover inhibitors of amyloid-beta peptide production and for diagnostic imaging
WO2001092235A1 (en) 2000-06-01 2001-12-06 Bristol-Myers Squibb Pharma Company LACTAMS SUBSTITUTED BY CYCLIC SUCCINATES AS INHIBITORS OF Aβ PROTEIN PRODUCTION
US20020115717A1 (en) * 2000-07-25 2002-08-22 Francine Gervais Amyloid targeting imaging agents and uses thereof
US7344702B2 (en) 2004-02-13 2008-03-18 Bristol-Myers Squibb Pharma Company Contrast agents for myocardial perfusion imaging
CH698246B1 (en) * 2001-12-20 2009-06-30 Hoffmann La Roche Test to identify inhibitors of beta secretases.
EP1482988A1 (en) * 2002-02-12 2004-12-08 Vistatec York Limited METHOD OF RADIO−LABELLING BIOMOLECULES
US20040223912A1 (en) * 2003-05-07 2004-11-11 Montalto Michael Christopher Compositions and methods for non-invasive imaging of soluble beta-amyloid
WO2004100998A2 (en) 2003-05-07 2004-11-25 General Electric Company Compositions and methods for non-invasive imaging of soluble beta-amyloid
JP2007504283A (en) * 2003-05-20 2007-03-01 ザ リージェンツ オブ ザ ユニバーシティ オブ カリフォルニア Method for binding agents to β-amyloid plaques
US20050214222A1 (en) * 2004-02-13 2005-09-29 Mckinnon Stuart J In vivo imaging of amyloid plaques in glaucoma using intravenous injectable dyes
WO2008118122A2 (en) * 2006-05-08 2008-10-02 Molecular Neuroimaging, Llc Compounds and amyloid probes thereof for therapeutic and imaging uses
AU2009220244B2 (en) 2008-02-29 2014-10-09 Lantheus Medical Imaging, Inc. Contrast agents for applications including perfusion imaging
US20100178245A1 (en) * 2009-01-13 2010-07-15 Arnsdorf Morton F Biocompatible Microbubbles to Deliver Radioactive Compounds to Tumors, Atherosclerotic Plaques, Joints and Other Targeted Sites
KR20170033873A (en) 2010-02-08 2017-03-27 랜티우스 메디컬 이메징, 인크. Methods and apparatus for synthesizing imaging agents, and intermediates thereof
CN103153168B (en) 2010-08-16 2016-03-09 康格诺皮蒂克斯公司 For detecting the system and method for amyloid
TWI530489B (en) 2011-03-22 2016-04-21 必治妥美雅史谷比公司 Bis(fluoroalkyl)-1,4-benzodiazepine compound
AU2013203000B9 (en) 2012-08-10 2017-02-02 Lantheus Medical Imaging, Inc. Compositions, methods, and systems for the synthesis and use of imaging agents
CN104797584A (en) 2012-09-21 2015-07-22 百时美施贵宝公司 Tricyclic heterocyclic compounds as notch inhibitors
WO2014047392A1 (en) 2012-09-21 2014-03-27 Bristol-Myers Squibb Company Fluoroalkyl-1,4-benzodiazepinone compounds
TWI614238B (en) 2012-09-21 2018-02-11 必治妥美雅史谷比公司 Bis(fluoroalkyl)-1,4-benzodiazepine compounds and prodrugs thereof
JP2015531792A (en) 2012-09-21 2015-11-05 ブリストル−マイヤーズ スクイブ カンパニーＢｒｉｓｔｏｌ−Ｍｙｅｒｓ Ｓｑｕｉｂｂ Ｃｏｍｐａｎｙ Prodrugs of 1,4-benzodiazepinone compounds
EP2897938B1 (en) 2012-09-21 2017-03-15 Bristol-Myers Squibb Company Fluoroalkyl dibenzodiazepinone compounds
EP2897942B1 (en) 2012-09-21 2016-08-31 Bristol-Myers Squibb Company Fluoroalkyl and fluorocycloalkyl 1,4-benzodiazepinone compounds as notch inhibitors
EP2897947B1 (en) 2012-09-21 2016-10-26 Bristol-Myers Squibb Company Alkyl, fluoroalkyl-1,4-benzodiazepinone compounds
US9187434B2 (en) 2012-09-21 2015-11-17 Bristol-Myers Squibb Company Substituted 1,5-benzodiazepinones compounds
CN104854097A (en) 2012-09-21 2015-08-19 百时美施贵宝公司 N-substituted bis(fluoroalkyl)-1,4-benzodiazepinone compounds
JP2016515625A (en) 2013-04-04 2016-05-30 ブリストル−マイヤーズ スクイブ カンパニーＢｒｉｓｔｏｌ−Ｍｙｅｒｓ Ｓｑｕｉｂｂ Ｃｏｍｐａｎｙ Combination therapy to treat proliferative diseases
CN113634240B (en) * 2021-08-26 2023-10-27 宏葵生物（中国）股份有限公司 Fluorescent magnetic composite nanofiber, preparation method and application thereof
PL247654B1 (en) * 2023-07-03 2025-08-18 Inst Chemii I Techniki Jadrowej Modified molecule of substance EG01377 and method of obtaining it, diagnostic or therapeutic receptor radiopharmaceutical based on this molecule, method of its production and use

Family Cites Families (86)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3828025A (en) * 1970-11-04 1974-08-06 Pfizer Phosphono substituted acylpenicillins
US4859777A (en) 1981-07-01 1989-08-22 Eastman Kodak Company Terpyridine chelating agents
US4666829A (en) 1985-05-15 1987-05-19 University Of California Polypeptide marker for Alzheimer's disease and its use for diagnosis
DE3688613T2 (en) * 1985-11-18 1994-01-13 Access Pharma Inc POLYCHELING SUBSTANCES FOR IMAGING AND SPECTRAL INCREASING (AND SPECTRAL SHIFT).
CA1305160C (en) 1985-12-23 1992-07-14 Paul Louis Bergstein Ether isonitriles and radiolabeled complexes thereof
US5252317A (en) 1986-11-10 1993-10-12 The State Of Oregon Acting By And Through The State Board Of Higher Education On Behalf Of The University Of Oregon Amplifier molecules for diagnosis and therapy derived from 3,5-bis[1-(3-amino-2,2-bis (aminomethyl)-propyl) oxymethyl] benzoic acid
US5567411A (en) 1986-11-10 1996-10-22 State Of Oregon Acting By And Through The State Board Of Higher Education On Behalf Of The University Of Oregon Dendritic amplifier molecules having multiple terminal active groups stemming from a benzyl core group
US5064956A (en) 1987-06-24 1991-11-12 The Dow Chemical Company Process for preparing mono-n-alkylated polyazamacrocycles
US5087440A (en) * 1989-07-31 1992-02-11 Salutar, Inc. Heterocyclic derivatives of DTPA used for magnetic resonance imaging
EP0411668B2 (en) * 1989-08-04 1998-11-11 MERCK SHARP & DOHME LTD. Central cholecystokinin antagonists for treatment of psychiatric disorders
GB8923843D0 (en) 1989-10-23 1989-12-13 Salutar Inc Compounds
US5679810A (en) 1990-01-19 1997-10-21 Salutar, Inc. Linear oligomeric polychelant compounds
WO1992017215A1 (en) 1990-03-28 1992-10-15 Nycomed Salutar, Inc. Contrast media
GB9006977D0 (en) 1990-03-28 1990-05-23 Nycomed As Compositions
US5434050A (en) 1991-08-13 1995-07-18 Regents Of The University Of Minnesota Labelled β-amyloid peptide and methods of screening for Alzheimer's disease
JP2556988Y2 (en) * 1991-08-28 1997-12-08 日本ヒューレット・パッカード株式会社 Terminal device for electrical connection
US5766846A (en) 1992-07-10 1998-06-16 Athena Neurosciences Methods of screening for compounds which inhibit soluble β-amyloid peptide production
ATE207064T1 (en) * 1992-07-29 2001-11-15 Merck Sharp & Dohme BENZODIAZEPINE DERIVATIVES
US5283241A (en) * 1992-08-28 1994-02-01 Merck & Co., Inc. Benzo-fused lactams promote release of growth hormone
MX9308016A (en) * 1992-12-22 1994-08-31 Lilly Co Eli HUMAN IMMUNODEFICIENCY VIRUS PROTEASE INHIBITING COMPOUNDS, PROCEDURE FOR THEIR PREPARATION AND PHARMACEUTICAL FORMULATION CONTAINING THEM.
US5760191A (en) 1993-02-05 1998-06-02 Nycomed Imaging As Macrocyclic complexing agents and targeting immunoreagents useful in therapeutic and diagnostic compositions and methods
US5744120A (en) * 1993-03-30 1998-04-28 The Dupont Merick Pharmaceutical Company Ternary radiopharmaceutical complexes
MXPA94002323A (en) 1993-03-31 2002-06-18 Mallinckrodt Medical Inc Radiopharmaceutical formulations having non-stannous reducers.
AU7102394A (en) * 1993-06-09 1995-01-03 Smithkline Beecham Corporation Bicyclic fibrinogen antagonists
ZA945719B (en) 1993-08-09 1996-02-01 Lilly Co Eli Identification and use of protease inhibitors
US5459954A (en) 1993-08-31 1995-10-24 Admotion Corporation Advertising display method and apparatus
ES2170104T3 (en) 1993-10-01 2002-08-01 Merrell Pharma Inc INHIBITORS OF THE PRODUCTION OF BETA-AMILOID PROTEINS.
US5417959A (en) 1993-10-04 1995-05-23 Mallinckrodt Medical, Inc. Functionalized aza-crytand ligands for diagnostic imaging applications
US5426185A (en) * 1993-11-22 1995-06-20 Merck & Co., Inc. Antiarrhythmic benzodiazepines
JPH10504545A (en) * 1994-07-29 1998-05-06 藤沢薬品工業株式会社 Benzodiazepine derivatives
US5661161A (en) * 1994-09-29 1997-08-26 Merck & Co., Inc. Inhibitors of farnesyl-protein transferase
US5520904A (en) 1995-01-27 1996-05-28 Mallinckrodt Medical, Inc. Calcium/oxyanion-containing particles with a polymerical alkoxy coating for use in medical diagnostic imaging
EP0727225A3 (en) 1995-02-14 1997-01-15 Sonus Pharma Inc Compositions and methods for directed ultrasound imaging
US5672598A (en) 1995-03-21 1997-09-30 The Procter & Gamble Company Lactam-containing hydroxamic acids
US5856326A (en) * 1995-03-29 1999-01-05 Merck & Co., Inc. Inhibitors of farnesyl-protein transferase
US5578629A (en) * 1995-03-29 1996-11-26 Merck & Co., Inc. Benzamide-containing inhibitors of farnesyl-protein transferase
US5710171A (en) * 1995-05-24 1998-01-20 Merck & Co., Inc. Bisphenyl inhibitors of farnesyl-protein transferase
EP0828754B1 (en) * 1995-05-29 2005-02-02 Pfizer Inc. Dipeptides which promote release of growth hormone
US5756528A (en) * 1995-06-06 1998-05-26 Merck & Co., Inc. Inhibitors of farnesyl-protein transferase
US5801228A (en) 1995-06-07 1998-09-01 Nycomed Imaging As Polymeric contrast agents for medical imaging
EP0761680A3 (en) * 1995-09-12 1999-05-06 Ono Pharmaceutical Co., Ltd. Tetrazole compounds having Interleukin-1beta converting enzyme inhibitory activity
US5879659A (en) * 1996-03-13 1999-03-09 Dupont Pharmaceuticals Company Ternary radiopharmaceutical complexes
US5852010A (en) * 1996-04-03 1998-12-22 Merck & Co., Inc. Inhibitors of farnesyl-protein transferase
US5919785A (en) * 1996-04-03 1999-07-06 Merck & Co., Inc. Inhibitors of farnesyl-protein transferase
US5869682A (en) * 1996-04-03 1999-02-09 Merck & Co., Inc. Inhibitors of farnesyl-protein transferase
US5859012A (en) * 1996-04-03 1999-01-12 Merck & Co., Inc. Inhibitors of farnesyl-protein transferase
US5885995A (en) * 1996-04-03 1999-03-23 Merck & Co., Inc. Inhibitors of farnesyl-protein transferase
US5891889A (en) * 1996-04-03 1999-04-06 Merck & Co., Inc. Inhibitors of farnesyl-protein transferase
US5804161A (en) 1996-05-14 1998-09-08 Nycomed Salutar Inc. Contrast agents
US5703129A (en) * 1996-09-30 1997-12-30 Bristol-Myers Squibb Company 5-amino-6-cyclohexyl-4-hydroxy-hexanamide derivatives as inhibitors of β-amyloid protein production
AR016751A1 (en) 1996-11-22 2001-08-01 Athena Neurosciences Inc METHOD FOR INHIBITING THE RELEASE OF THE BETA-AMYLOID PEPTIDE IN A CELL, PHARMACEUTICAL COMPOSITION AND USEFUL COMPOUNDS IN THIS METHOD
IL129238A0 (en) 1996-11-22 2000-02-17 Elan Pharm Inc N-(aryl/heteroarylacetyl) amino acid esters pharmaceutical compositions comprising same and methods for inhibiting b-amyloid peptide release and/ or its synthesis by use of such compounds
WO1998022441A2 (en) 1996-11-22 1998-05-28 Elan Pharmaceuticals, Inc. N-(aryl/heteroaryl) amino acid esters, pharmaceutical compositions, and methods for inhibiting beta-amyloid peptide and/or its synthesis
NZ335157A (en) 1996-11-22 2001-01-26 Elan Pharm Inc N-(aryl/heteroaryl) amino acid derivatives and methods for inhibiting beta-amyloid peptide release or its synthesis
AU729133B2 (en) 1996-11-22 2001-01-25 Elan Pharmaceuticals, Inc. N-(aryl/heteroaryl/alkylacetyl) amino acid amides, pharmaceutical compositions comprising same, and methods for inhibiting beta-amyloid peptide release and/or its synthesis by use of such compounds
IL158355A0 (en) 1996-12-23 2004-05-12 Elan Pharm Inc CYCLOALKYL, LACTAM, LACTONE AND RELATED COMPOUNDS AND PHARMACEUTICAL COMPOSITIONS AS beta-AMYLOID PEPTIDE RELEASE INHIBITORS AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM
FR2760024B1 (en) 1997-02-21 1999-05-14 Centre Nat Rech Scient PROCESS FOR CHARACTERIZING DUPLEX OF NUCLEIC ACID
HRP980093A2 (en) 1997-02-28 1998-12-31 Lilly Co Eli Heterocyclic compounds, pharmaceutical compositions comprising same, and methods for inhibiting "beta"-amyloid peptide release and/or its synthesis by use of such compounds
GB9721373D0 (en) 1997-10-08 1997-12-10 Johnson & Son Inc S C Improvements in liquid compositions
US5836690A (en) 1997-12-17 1998-11-17 Ultimate Environmental Mixing, Inc. Rotatable mixing head having sealed bearings
JP2002518481A (en) 1998-06-22 2002-06-25 エラン ファーマシューティカルズ，インコーポレイテッド Compounds for inhibiting the release of β-amyloid peptide and / or its synthesis
EP1093372A4 (en) 1998-06-22 2004-09-29 Elan Pharm Inc CYCLIC AMINO ACID COMPOUNDS, PHARMACEUTICAL COMPOSITIONS COMPRISING SAME, AND METHODS FOR INHIBITING $g(b)-AMYLOID PEPTIDE RELEASE AND/OR ITS SYNTHESIS BY USE OF SUCH COMPOUNDS
AU5204799A (en) 1998-06-22 2000-01-10 Elan Pharmaceuticals, Inc. Compounds for inhibiting beta-amyloid peptide release and/or its synthesis
JP2002518483A (en) 1998-06-22 2002-06-25 エラン ファーマシューティカルズ，インコーポレイテッド Compounds for inhibiting β-amyloid peptide release and / or their synthesis
HRP990246A2 (en) 1998-08-07 2000-06-30 Du Pont Pharm Co Succinoylamino benzodiazepines as inhibitors of a beta protein production
WO2000024392A1 (en) 1998-10-26 2000-05-04 Sumitomo Pharmaceuticals Company, Limited β-AMYLOID FORMATION INHIBITORS
GB9823499D0 (en) 1998-10-27 1998-12-23 Proman Chem Ltd Barrier coatings
DE19851456A1 (en) 1998-11-09 2000-05-11 Bosch Gmbh Robert Device and method for moving parts
CA2346099A1 (en) 1998-11-12 2000-05-18 Dupont Pharmaceuticals Company Use of radioligands to screen inhibitors of amyloid-beta peptide production
IL142816A0 (en) * 1998-12-24 2002-03-10 Du Pont Pharm Co SUCCINOYLAMINO BENZODIAZEPINES AS INHIBITORS OF Aβ PROTEIN PRODUCTION
WO2000047618A2 (en) * 1999-02-10 2000-08-17 Elan Pharmaceuticals, Inc. HUMAN β-SECRETASE ENZYME, INHIBITORS AND THEIR COMPOSITIONS AND USES
AT409441B (en) 1999-07-16 2002-08-26 Koenig Maschinen Gmbh DEVICE FOR MOLDING A CONTINUOUS DUMP BAND FROM AN UNFORMED Dough
WO2001009703A1 (en) 1999-08-02 2001-02-08 Harris Interactive, Inc. System for protecting information over the internet
US6494531B1 (en) 1999-08-04 2002-12-17 Hoon Y. Kim Vehicle seat for reversible occupant travel
GB9918586D0 (en) 1999-08-07 1999-10-06 British Gas Plc Compact reactor
DE19937511A1 (en) 1999-08-09 2001-02-15 Rainer Hartmann Procedure for adjusting parabolic antennas
US6171262B1 (en) 1999-08-11 2001-01-09 Creative Plastic Technology, Llc Retractable blood collection device
AU783914B2 (en) 1999-09-13 2005-12-22 Bristol-Myers Squibb Pharma Company Hydroxyalkanoyl aminolactams and related structures as inhibitors of a beta protein production
ES2223588T3 (en) 1999-10-13 2005-03-01 Banyu Pharmaceutical Co., Ltd. IMIDAZOLIDINONA SUBSTITUTED DERIVATIVES.
EP1261610A2 (en) 2000-02-17 2002-12-04 Bristol-Myers Squibb Pharma Company Succinoylamino carbocycles and heterocycles as inhibitors of a-beta protein production
CA2401120A1 (en) * 2000-03-28 2001-10-04 Dupont Pharmaceuticals Company Lactams as inhibitors of a-beta protein production
CA2404314A1 (en) 2000-03-31 2001-10-11 Lorin Andrew Thompson Succinoylamino heterocycles as inhibitors of a.beta. protein production
MXPA02009729A (en) 2000-04-03 2003-03-27 Bristol Myers Squibb Pharma Co CYCLIC LACTAMS AS INHIBITORS OF A beta PROTEIN PRODUCTION.
IL151576A0 (en) 2000-04-03 2003-04-10 Bristol Myers Squibb Pharma Co Cyclic lactams as inhibitors of a-beta protein production
US6632812B2 (en) 2000-04-11 2003-10-14 Dupont Pharmaceuticals Company Substituted lactams as inhibitors of Aβ protein production
WO2001092235A1 (en) * 2000-06-01 2001-12-06 Bristol-Myers Squibb Pharma Company LACTAMS SUBSTITUTED BY CYCLIC SUCCINATES AS INHIBITORS OF Aβ PROTEIN PRODUCTION

Also Published As

Publication number Publication date
WO2001087354A2 (en) 2001-11-22
US6878363B2 (en) 2005-04-12
US20020159947A1 (en) 2002-10-31
WO2001087354A3 (en) 2002-08-22
US20050129612A1 (en) 2005-06-16

Similar Documents

Publication Publication Date Title
AU2001261728A1 (en) Use of small molecule radioligands for diagnostic imaging
AU2001227815A1 (en) Chemically specific imaging of tissue
AU2002331850A1 (en) Methods of endobronchial diagnosis using imaging
AU2002357155A1 (en) Endoscopic imaging system
EP1126287A3 (en) Ultrasonic diagnosis apparatus
AU1769101A (en) Graphical user interface for in-vivo imaging
AU2001273505A1 (en) Single-use radiological imaging aid
AU2001280061A1 (en) Measurement of critical dimensions using x-rays
AU2001288462A1 (en) Medical instrument
AU2001232360A1 (en) Medical instrument
AU2002251739A1 (en) Activatable imaging probes
AU2002346086A1 (en) Diagnostic imaging tabletop
AUPQ886100A0 (en) Diagnostic test
AU2002357002A1 (en) Diagnostic sensing apparatus
AU2002245169A1 (en) Fullerene (c60)-based x-ray contrast agent for diagnostic imaging
AU5920899A (en) Imaging of surgical biopsies
AU2001236592A1 (en) Methods for diagnosis of alzheimer's disease
AU2000268695A1 (en) Imaging apparatus
AU2002228725A1 (en) Nucleophilic approach for preparing radiolabeled imaging agents and associated compounds
AU2001264631A1 (en) Medical instrument
AU2002239244A1 (en) Apparatus for the transillumination imaging of teeth
AU2001255580A1 (en) Methods and compositions for the diagnosis of schizophrenia
AU2001242297A1 (en) Positioning aid for tomographic functional examination of the lumbar column
AU2002210438A1 (en) Diagnosis of diseases which are associated with cd24
AU2003283648A1 (en) Compounds as radioligands for the diagnosis of disease